Aclaris Therapeutics Inc. (ACRS)
Aclaris Therapeutics Max Pain By Strike
ACRS trades at $1.86, 7.0% below the near-term max pain of $2 expiring Oct 17, 2025 (12 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($0.5-$7), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Aclaris Therapeutics Max Pain By Expiry
Max pain for ACRS shows a downward trend from 7 to 0.5, indicating bearish sentiment or hedging activity. The 300% spread signals divergent expectations across timeframes. Levels distributed around 1.86. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Oct 17, 2025 | 2 | n/a (n/a) |
Nov 21, 2025 | 2 | n/a (n/a) |
Dec 19, 2025 | 1 | n/a (n/a) |
Jan 16, 2026 | 7 | n/a (n/a) |
Feb 20, 2026 | 0.5 | n/a (n/a) |
May 15, 2026 | 0.5 | n/a (n/a) |